Literature DB >> 9831401

Clinical pattern of corticosteroid dependent Crohn's disease.

D P Franchimont1, E Louis, F Croes, J Belaiche.   

Abstract

OBJECTIVES: Corticosteroid dependency in Crohn's disease (CD) is characterized by the need for chronic use of corticosteroids to maintain clinical remission. Several definitions have been used. Depending on the definition, 10-30% of the patients are considered as corticosteroid dependent. The aim of the study was to define a clinical pattern of corticosteroid dependent CD patients. PATIENTS AND METHODS: Epidemiological and clinical characteristics were retrospectively compared between 20 corticosteroid dependent CD patients and 248 non-corticosteroid dependent CD patients by using univariate and multivariate analyses. Corticosteroid dependency was defined either by two successive relapses during the 2 months after discontinuing glucocorticoids (n=5) or by two successive relapses at dose tapering, after successful treatment of a flare-up by using glucocorticoids (n=15).
RESULTS: Corticosteroid dependent CD patients were younger at diagnosis (P < 0.001), and were characterized by a higher frequency of colonic location (P< 0.05), but lower frequency of ileal location (P < 0.01), and higher ano-perineal location (P < 0.05). They were also more frequently smokers (P< 0.05) and users of contraceptive pills (P< 0.01). The inflammatory type of the disease was increased (P < 0.01), while the fibrostenotic type was decreased (P < 0.001) in corticosteroid dependent CD patients. By multivariate analysis, a smoking habit (P < 0.01), a colonic location (P < 0.05), a non-fibrostenotic type (P< 0.05) and a younger age at diagnosis (P< 0.05) were shown to be independently associated with corticosteroid dependency.
CONCLUSIONS: This study suggests a clinical pattern associated with corticosteroid dependency. Whether this clinical pattern is simply associated with the dependency, or whether a primary decrease of corticosensitivity produces this clinical pattern, is not known. Further prospective studies will have to determine whether the presence of these clinical characteristics is predictive of corticosteroid dependency and whether this prediction will be useful for the management of this condition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831401     DOI: 10.1097/00042737-199810000-00001

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

Review 1.  Top-down therapy for IBD: rationale and requisite evidence.

Authors:  Geert R D'Haens
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

2.  Crohn's disease: the subsequent visit.

Authors:  Catherine S Manolakis; Francis A Farraye; Jack A Di Palma
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 3.  Steroid use in Crohn's disease.

Authors:  Stephan R Vavricka; Alain M Schoepfer; Michael Scharl; Gerhard Rogler
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

4.  Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.

Authors:  Anthony Buisson; Wing Yan Mak; Michael J Andersen; Donald Lei; Stacy A Kahn; Joel Pekow; Russel D Cohen; Nada Zmeter; Bruno Pereira; David T Rubin
Journal:  J Crohns Colitis       Date:  2019-08-14       Impact factor: 9.071

Review 5.  The potential for disease modification in Crohn's disease.

Authors:  G Van Assche; Séverine Vermeire; Paul Rutgeerts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

6.  Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.

Authors:  B Weiss; O Lebowitz; H H Fidder; I Maza; A Levine; R Shaoul; S Reif; Y Bujanover; A Karban
Journal:  Dig Dis Sci       Date:  2009-08-20       Impact factor: 3.199

Review 7.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

Review 8.  Health maintenance and inflammatory bowel disease.

Authors:  Catherine S Manolakis; Brooks D Cash
Journal:  Curr Gastroenterol Rep       Date:  2014-10

9.  Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trial.

Authors:  Walter Reinisch; Robert Knobler; Paul J Rutgeerts; Thomas Ochsenkühn; Frank Anderson; Christian von Tirpitz; Martin Kaatz; C Janneke van der Woude; Dennis Parenti; Peter J Mannon
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

Review 10.  Medical Therapy of Fibrostenotic Crohn's Disease.

Authors:  Britta Siegmund
Journal:  Viszeralmedizin       Date:  2015-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.